Tom Feegel, CEO of Beond - Ending the Opiate Addiction Epidemic with Safe Ibogaine Treatment
Explicit content warning
03/27/22 • 58 min
Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.
In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction. Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.
Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.
In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction. Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.
Previous Episode
Dillan DiNardo - CEO of Mindstate Design Labs | Creating Novel Psychoactive Drugs at Y Combinator
Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.
Mindstate's mission is to map the biological basis of the varieties of psychedelic experience, and to use that map to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders. Mindstate participated in Y Combinator in 2021.
Check out Mindstate @ https://www.mindstate.design/
Next Episode
Music For Psychedelic Therapy - Mendel Kaelen, Founder and CEO of Wavepaths
Mendel Kaelen is the CEO of Wavepaths. Prior to founding Wavepaths, Mendel Kaelen worked as a PhD and postdoctoral neuroscientist at Imperial College London since 2012, where his research was the one of the first to demonstrate music’s central role in psychedelic therapies. Wavepaths is a software platform that generates personalized, optimal music for psychedelic therapy.
0:00 - Why work on music and psychedelics?
3:30 - Highlights of Mendel’s academic career.
7:30 - Is there a universal “best” music for psychedelic therapy? How to design a psychedelic therapy playlist.
11:30 - What does the importance of music personalization mean for group psychedelic sessions?
16:00 - Should music for psychedelics be “familiar” to the patient, or novel?
20:00 - Vocals vs no vocals? It’s not that simple.
23:00 - Directive vs non-directive and concrete vs fluid music.
25:00 - Is the “right” music for psychedelics consistent across different drugs?
28:00 - How did Mendel switch from academia to startup founder.
30:30 - What is Wavepaths?
35:30 - Who is Wavepaths for?
37:00 - How do you sell music for psychedelic therapy?
39:00 - Surprising insights from Wavepaths customers?
43:30 - How does Wavepaths use biofeedback?
46:00 - Wavepaths direct to consumer.
49:45 - Startup life vs academia.
51:00 - Virtual reality and psychedelic therapy.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/brom-rector-350429/tom-feegel-ceo-of-beond-ending-the-opiate-addiction-epidemic-with-safe-50734581"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to tom feegel, ceo of beond - ending the opiate addiction epidemic with safe ibogaine treatment on goodpods" style="width: 225px" /> </a>
Copy